Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 409

1.

A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies.

Parmar SR, Bhatt V, Yang J, Zhang Q, Schuster M.

J Oncol Pharm Pract. 2014 Jun;20(3):172-82. doi: 10.1177/1078155213490004. Epub 2013 Jun 26.

PMID:
23804627
2.

Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.

Nelson R.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD004610. Review. Update in: Cochrane Database Syst Rev. 2011;(9):CD004610.

PMID:
17636768
3.

Prospective observational study comparing three different treatment regimes in patients with Clostridium difficile infection.

Wenisch JM, Schmid D, Kuo HW, Allerberger F, Michl V, Tesik P, Tucek G, Laferl H, Wenisch C.

Antimicrob Agents Chemother. 2012 Apr;56(4):1974-8. doi: 10.1128/AAC.05647-11. Epub 2012 Jan 17.

4.

Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.

Nelson RL, Kelsey P, Leeman H, Meardon N, Patel H, Paul K, Rees R, Taylor B, Wood E, Malakun R.

Cochrane Database Syst Rev. 2011 Sep 7;(9):CD004610. doi: 10.1002/14651858.CD004610.pub4. Review. Update in: Cochrane Database Syst Rev. 2017 Mar 03;3:CD004610.

PMID:
21901692
5.

Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.

Bricker E, Garg R, Nelson R, Loza A, Novak T, Hansen J.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD004610. Review. Update in: Cochrane Database Syst Rev. 2007;(3):CD004610.

PMID:
15674956
6.

Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.

Al-Nassir WN, Sethi AK, Nerandzic MM, Bobulsky GS, Jump RL, Donskey CJ.

Clin Infect Dis. 2008 Jul 1;47(1):56-62. doi: 10.1086/588293.

PMID:
18491964
7.

Clostridium difficile infection and treatment in the pediatric inflammatory bowel disease population.

Mezoff E, Mann EA, Hart KW, Lindsell CJ, Cohen MB.

J Pediatr Gastroenterol Nutr. 2011 Apr;52(4):437-41. doi: 10.1097/MPG.0b013e3181f97209.

8.

Clostridium difficile infection in older adults: a review and update on its management.

Kee VR.

Am J Geriatr Pharmacother. 2012 Feb;10(1):14-24. doi: 10.1016/j.amjopharm.2011.12.004. Epub 2012 Jan 20. Review.

PMID:
22260856
9.

Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.

P├ępin J, Valiquette L, Gagnon S, Routhier S, Brazeau I.

Am J Gastroenterol. 2007 Dec;102(12):2781-8. Epub 2007 Sep 26.

PMID:
17900327
10.

The evolution of urban C. difficile infection (CDI): CDI in 2009-2011 is less severe and has better outcomes than CDI in 2006-2008.

Feuerstadt P, Das R, Brandt LJ.

Am J Gastroenterol. 2014 Aug;109(8):1265-76. doi: 10.1038/ajg.2014.167. Epub 2014 Jul 8.

PMID:
25001255
11.
12.

A meta-analysis of metronidazole and vancomycin for the treatment of Clostridium difficile infection, stratified by disease severity.

Di X, Bai N, Zhang X, Liu B, Ni W, Wang J, Wang K, Liang B, Liu Y, Wang R.

Braz J Infect Dis. 2015 Jul-Aug;19(4):339-49. doi: 10.1016/j.bjid.2015.03.006. Epub 2015 May 19. Review.

13.

Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting.

Venugopal AA, Riederer K, Patel SM, Szpunar S, Jahamy H, Valenti S, Shemes SP, Khatib R, Johnson LB.

Scand J Infect Dis. 2012 Apr;44(4):243-9. doi: 10.3109/00365548.2011.631029. Epub 2011 Nov 13.

PMID:
22077148
14.

Outcomes from rectal vancomycin therapy in patients with Clostridium difficile infection.

Saffouri G, Khanna S, Estes L, Pardi D.

Am J Gastroenterol. 2014 Jun;109(6):924-5. doi: 10.1038/ajg.2014.80. No abstract available.

PMID:
24896763
15.

A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.

Zar FA, Bakkanagari SR, Moorthi KM, Davis MB.

Clin Infect Dis. 2007 Aug 1;45(3):302-7. Epub 2007 Jun 19.

PMID:
17599306
16.

Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease.

McFarland LV, Elmer GW, Surawicz CM.

Am J Gastroenterol. 2002 Jul;97(7):1769-75.

PMID:
12135033
17.

The clinical spectrum of Clostridium difficile colitis in immunocompromised patients.

Schweitzer MA, Sweiss I, Silver DL, Stellato TA.

Am Surg. 1996 Jul;62(7):603-7; discussion 607-8.

PMID:
8651560
18.

The Addition of Intravenous Metronidazole to Oral Vancomycin is Associated With Improved Mortality in Critically Ill Patients With Clostridium difficile Infection.

Rokas KE, Johnson JW, Beardsley JR, Ohl CA, Luther VP, Williamson JC.

Clin Infect Dis. 2015 Sep 15;61(6):934-41. doi: 10.1093/cid/civ409. Epub 2015 May 29.

PMID:
26024909
19.

Comparative effectiveness of Clostridium difficile treatments: a systematic review.

Drekonja DM, Butler M, MacDonald R, Bliss D, Filice GA, Rector TS, Wilt TJ.

Ann Intern Med. 2011 Dec 20;155(12):839-47. doi: 10.7326/0003-4819-155-12-201112200-00007. Review.

PMID:
22184691
20.

Rifaximin in the treatment of recurrent Clostridium difficile infection.

Mattila E, Arkkila P, Mattila PS, Tarkka E, Tissari P, Anttila VJ.

Aliment Pharmacol Ther. 2013 Jan;37(1):122-8. doi: 10.1111/apt.12111. Epub 2012 Oct 24.

Supplemental Content

Support Center